These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15488103)

  • 21. Predictors of 4-year outcome of community residential treatment for patients with substance use disorders.
    Laffaye C; McKellar JD; Ilgen MA; Moos RH
    Addiction; 2008 Apr; 103(4):671-80. PubMed ID: 18339113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teenagers are right--parents do not know much: an analysis of adolescent-parent agreement on reports of adolescent substance use, abuse, and dependence.
    Fisher SL; Bucholz KK; Reich W; Fox L; Kuperman S; Kramer J; Hesselbrock V; Dick DM; Nurnberger JI; Edenberg HJ; Bierut LJ
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1699-710. PubMed ID: 17010137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family-based therapies for adolescent alcohol and drug use: research contributions and future research needs.
    Liddle HA
    Addiction; 2004 Nov; 99 Suppl 2():76-92. PubMed ID: 15488107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance use disorder among adoptees: a clinical comparative study.
    Westermeyer J; Bennett L; Thuras P; Yoon G
    Am J Drug Alcohol Abuse; 2007; 33(3):455-66. PubMed ID: 17613973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences. A study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway.
    Bakken K; Landheim AS; Vaglum P
    Drug Alcohol Depend; 2005 Dec; 80(3):321-8. PubMed ID: 15964156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98.
    Humphreys K; Weingardt KR; Horst D; Joshi AA; Finney JW
    Addiction; 2005 Sep; 100(9):1249-57. PubMed ID: 16128714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-validation of the alcohol and cannabis use measures in the Global Appraisal of Individual Needs (GAIN) and Timeline Followback (TLFB; Form 90) among adolescents in substance abuse treatment.
    Dennis ML; Funk R; Godley SH; Godley MD; Waldron H
    Addiction; 2004 Nov; 99 Suppl 2():120-8. PubMed ID: 15488110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression to the mean in substance use disorder treatment research.
    Finney JW
    Addiction; 2008 Jan; 103(1):42-52. PubMed ID: 17999707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
    Faraone SV; Biederman J; Wilens TE; Adamson J
    Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of publicly funded managed care on adolescent substance abuse treatment outcomes.
    Harrow BS; Tompkins CP; Mitchell PD; Smith KW; Soldz S; Kasten L; Fleming K
    Am J Drug Alcohol Abuse; 2006; 32(3):379-98. PubMed ID: 16864469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM).
    Lawrinson P; Copeland J; Indig D
    Drug Alcohol Depend; 2005 Oct; 80(1):125-33. PubMed ID: 15869845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contingency management for treatment of substance use disorders: a meta-analysis.
    Prendergast M; Podus D; Finney J; Greenwell L; Roll J
    Addiction; 2006 Nov; 101(11):1546-60. PubMed ID: 17034434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
    Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
    Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcome studies on physician impairment: a review of the literature.
    Femino J; Nirenberg TD
    R I Med; 1994 Oct; 77(10):345-50. PubMed ID: 7803865
    [No Abstract]   [Full Text] [Related]  

  • 39. Methodological and statistical considerations in measuring alcohol treatment effects.
    Stout RL
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1686-91. PubMed ID: 14574242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Latent class analysis of substance abuse patterns.
    Uebersax JS
    NIDA Res Monogr; 1994; 142():64-80. PubMed ID: 9243533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.